58 related articles for article (PubMed ID: 8392215)
1. [Diagnostic and therapeutic integration in non-small cell lung tumors: preliminary notes].
Marano P; Balducci M; Cellini N; Macis G; Mantini G; Pirronti T; Sallustio G; Trodella L; Turriziani A; Picciocchi A
Radiol Med; 1993 May; 85(5):588-99. PubMed ID: 8392215
[TBL] [Abstract][Full Text] [Related]
2. FDG-PET imaging for lymph node staging and pathologic tumor response after neoadjuvant treatment of non-small cell lung cancer.
Ohtsuka T; Nomori H; Ebihara A; Watanabe K; Kaji M; Naruke T; Suemasu K; Uno K
Ann Thorac Cardiovasc Surg; 2006 Apr; 12(2):89-94. PubMed ID: 16702929
[TBL] [Abstract][Full Text] [Related]
3. Value of PET/CT versus enhanced CT for locoregional lymph nodes in non-small cell lung cancer.
Yang W; Fu Z; Yu J; Yuan S; Zhang B; Li D; Xing L; Zhao D; Mu D; Sun X; Fang Y; Huang Y; Li W
Lung Cancer; 2008 Jul; 61(1):35-43. PubMed ID: 18177978
[TBL] [Abstract][Full Text] [Related]
4. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
[TBL] [Abstract][Full Text] [Related]
5. Restaging patients with N2 (stage IIIa) non-small cell lung cancer after neoadjuvant chemoradiotherapy: a prospective study.
Cerfolio RJ; Bryant AS; Ojha B
J Thorac Cardiovasc Surg; 2006 Jun; 131(6):1229-35. PubMed ID: 16733150
[TBL] [Abstract][Full Text] [Related]
6. [RAdio-chemo-surgical combined treatment of non-small cell lung carcinoma N2].
Rovea P; Sola B; Boidi Trotti A; Gabriele AM; Fracchia F; Casadio C; Bretti S
Radiol Med; 1993 Jun; 85(6):840-3. PubMed ID: 8393206
[TBL] [Abstract][Full Text] [Related]
7. Induction therapy in non-small-cell lung cancer: a comparison of clinical and post-surgical staging.
Granone PL; Margaritora S; Cesario A; Galetta D
Ann Ital Chir; 1999; 70(6):899-903. PubMed ID: 10804669
[TBL] [Abstract][Full Text] [Related]
8. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
Srisam-Ang K; Podhipak A; Narksawat K; Supaattagorn P; Tipayamongkholgul M
Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558
[TBL] [Abstract][Full Text] [Related]
9. Subcategorization of resectable non-small cell lung cancer involving neighboring structures.
Sakakura N; Mori S; Ishiguro F; Fukui T; Hatooka S; Shinoda M; Yokoi K; Mitsudomi T
Ann Thorac Surg; 2008 Oct; 86(4):1076-83; discussion 1083. PubMed ID: 18805135
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
[TBL] [Abstract][Full Text] [Related]
11. Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease.
Keller SM; Vangel MG; Wagner H; Schiller JH; Herskovic A; Komaki R; Marks RS; Perry MC; Livingston RB; Johnson DH;
J Thorac Cardiovasc Surg; 2004 Jul; 128(1):130-7. PubMed ID: 15224032
[TBL] [Abstract][Full Text] [Related]
12. [Multimodal treatment of non small cell lung cancer].
Stoelben E; Digel W; Henke M; Passlick B
Zentralbl Chir; 2006 Apr; 131(2):110-4. PubMed ID: 16612776
[TBL] [Abstract][Full Text] [Related]
13. Thoracoscopic staging of IIIB non-small cell lung cancer before neoadjuvant therapy.
De Giacomo T; Rendina EA; Venuta F; Della Rocca G; Ricci C
Ann Thorac Surg; 1997 Nov; 64(5):1409-11. PubMed ID: 9386712
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of non-resectable stage III non-small cell lung cancer].
Fournel P
Rev Pneumol Clin; 2004 Nov; 60(5 Pt 2):3S43-7. PubMed ID: 15536352
[TBL] [Abstract][Full Text] [Related]
15. Stage IIIB non-small-cell lung cancer.
Rendina EA; Venuta F; De Giacomo T; Furio Coloni G
Chest Surg Clin N Am; 2001 Feb; 11(1):101-19, viii. PubMed ID: 11253593
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic strategies in superior sulcus tumors: a model for combined modality therapy in non-small cell lung cancer].
Girard N; Mornex F
Cancer Radiother; 2007; 11(1-2):59-66. PubMed ID: 17197220
[TBL] [Abstract][Full Text] [Related]
17. [Guideline on 'non-small cell lung carcinoma; staging and treatment'].
van Meerbeeck JP; Koning CC; Tjan-Heijnen VC; Boekema AG; Kaandorp CJ; Burgers JS
Ned Tijdschr Geneeskd; 2005 Jan; 149(2):72-7. PubMed ID: 15688837
[TBL] [Abstract][Full Text] [Related]
18. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
[TBL] [Abstract][Full Text] [Related]
19. Serum biomarkers facilitate the recognition of early- stage cancer and may guide the selection of surgical candidates: a study of carcinoembryonic antigen and tissue polypeptide antigen in patients with operable non-small cell lung cancer.
Buccheri G; Ferrigno D
J Thorac Cardiovasc Surg; 2001 Nov; 122(5):891-9. PubMed ID: 11689793
[TBL] [Abstract][Full Text] [Related]
20. Solitary primary tracheal small-cell lung cancer causing acute respiratory failure: diagnosis and treatment.
Lan CC; Yang MC; Lee CH; Huang SF; Wu YK
Respir Care; 2010 Jul; 55(7):929-32. PubMed ID: 20587106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]